
Was James Lewis The Tylenol Killer? The Chilling True Story Behind Netflix's Docuseries
Four decades after the Tylenol murders caused mass panic in Chicago and across the country, Netflix's new docuseries Cold Case: The Tylenol Murders is revisiting the unsolved case. What happened in one of the largest criminal investigations in U.S. history, and why has justice never been served?
In 1982, seven people in the Chicago area died under the same mysterious circumstances: they had all taken Extra-Strength Tylenol. After testing, each of the capsules was found to be laced with potassium cyanide at toxic levels high enough to provide 'thousands of fatal doses,' Time Magazine reported.
News of the poisoned capsules sparked fear among the six million residents of the Chicago area. Health officials quickly advised the public to stop using the over-the-counter medication, and authorities went door-to-door warning residents of the potential danger.
From directors Yotam Guendelman and Ari Pines, Cold Case: The Tylenol Murders dives into the 'shocking theories and evidence, looks at new testimonies, and even gets inside the mind of a key suspect,' according to Netflix's Tudum.
Read on for a deeper dive into the Tylenol Murders, including who the victims were, the main person of interest James Lewis, and what happened to Johnson & Johnson during the investigation.
Cold Case: The Tylenol Murders
The first victim was 12-year-old Mary Kellerman, whose parents gave her Tylenol after she complained of a cold. She died just hours later. Postal worker Adam Janus died later that morning after taking the pills for chest pain. While mourning his death, Adam's brother, Stanley, and Stanley's wife, Theresa, who were both suffering from headaches, also took Tylenol and died later that day.
Another victim was 27-year-old Mary Reiner, who had just returned home after giving birth to her first child. Paula Prince, a 35-year-old United Airlines flight attendant, was also found dead in her apartment with an open Tylenol bottle nearby. Paramedics said there was so much cyanide on her lips that anyone who tried to resuscitate her might have been poisoned as well.
The seventh victim was 31-year-old Mary McFarland of Elmhurst, who collapsed at work after taking Tylenol for a headache. A pathologist's test found cyanide in her blood, the New York Times reported at the time.
The Netflix documentary notes that there could be more victims, as cyanide tests are rarely included in a standard autopsy toxicology screen unless there is a specific reason to suspect poisoning. For example, if an elderly person had ingested cyanide, the cause of death might have been harder to detect.
American businessman and CEO of Johnson and Johnson, James Burke, New Brunswick, New Jersey, 1981. ... More (Photo by Brownie Harris/Corbis via Getty Images)
In the early days of the investigation, Johnson & Johnson executives feared they might bear some responsibility for the murders, according to the Netflix docuseries. At the time, Tylenol was the pharmaceutical company's most profitable product. Illinois Attorney General Tyrone Fahner, who was interviewed in the series, recalled telling Johnson & Johnson to stop selling Tylenol – prompting what would become the largest product recall in history.
While testing the contents of the Tylenol bottles, investigators noticed that some capsules had brown rings forming at the ends, evidence of cyanide corrosion. It became clear that the capsules had been pulled apart, emptied of their medicine, and refilled with cyanide.
It was also revealed that the contaminated pills came from two different manufacturing plants, one in suburban Philadelphia and the other in Texas. After both facilities showed no evidence of cyanide tampering, investigators began to suspect that someone had tampered with the capsules after they reached store shelves. The tainted Tylenol bottles had been sold at various drugstores across the Chicago area.
Cold Case: The Tylenol Murders
Police had no major investigative leads, no connections between the victims, no witnesses, and no clear motive until October 6, 1982. Seven days after the murders, Johnson & Johnson received an extortion letter threatening that more people would be poisoned if certain demands were not met. The letter demanded that $1 million be deposited into an account at Chicago's Continental Bank or a second wave of killings would follow.
Investigators believed the person who wrote the letter was likely involved, as he demonstrated specific knowledge about poison and how it works. The bank account was linked to a travel agency called Lakeside Travel, owned by Fred Miller McCahey, a wealthy businessman. McCahey told authorities he had recently gotten into a dispute with a volatile man named Robert Richardson, the husband of one of his employees, Nancy Richardson.
Employees at the travel agency noted that the handwriting on the extortion letter resembled Robert's. Handwriting experts later confirmed that it was identical. After Robert and Nancy fled, authorities attempted to track him down using a photo published alongside an article he had written for the Chicago Tribune. Investigators also noted that he resembled the man seen in surveillance footage from the store where Mary McFarland had purchased the lethal Tylenol, per Cold Case.
James Lewis in "Cold Case: The Tylenol Murders."
David Barton, a former sergeant with the Kansas City, Missouri Police Department, recalled seeing a photo of Richardson on the news and immediately sensing something was off. 'I looked at the picture, and I immediately recognized him, jumped up off the couch and said, 'Goddam it, that's not Robert Richardson,'' Barton told Netflix. 'That's not Robert Richardson… that's James Lewis.'
Lewis, a tax consultant, became the police's prime suspect in the Tylenol murders. He also had a criminal history. In 1978, Lewis was charged with murder in Kansas City after police discovered the dismembered remains of one of his former clients, Raymond West, in bags in his attic.
Authorities also found a forged check that Lewis tried to cash from West's account. However, charges were dropped after a judge ruled that the search of Lewis' home was illegal, according to Time.com. In 2004, he was charged with rape and kidnapping, but the case was dropped.
Lewis was interviewed for Netflix's docuseries, where he denied any involvement in the crimes. "They make it look like I'm the world's most horrible, dangerous person ever... and I wouldn't hurt anybody," Lewis said.
Lewis was convicted of extortion for the letter and spent more than 12 years in federal prison. 'I did not consider it an extortion letter because I did not actually have access to making any money from that letter,' he told Netflix.
Although officials found drafts of extortion letters in James Lewis's home, along with a book about poisonings, tying him directly to the Tylenol murders was difficult. He was never charged with the killings because authorities could not confirm that he was in the Chicago area during the murders. He had reportedly taken an Amtrak train to New York City and was staying in a hotel there, but police couldn't prove that he returned to Chicago.
The FBI reopened the investigation in early 2009 and continued to focus on Lewis. They searched his office in Cambridge, Massachusetts, as well as a nearby storage unit he had rented. According to CBS News, in September 2022, members of the task force returned to Boston to re-interview him.
Lewis passed away in 2023.
IRVINE, CALIFORNIA - OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on ... More October 17, 2023 in Irvine, California. Johnson & Johnson beat Wall Street's quarterly revenue and earnings estimates as sales in its pharmaceutical and medical devices businesses grew. (Photo by)
Johnson & Johnson has denied that there was any chance their pills could have been tampered with at their factories, claiming that no cyanide was used in their facilities. However, as the documentary reveals, that turned out to be false.
'Cyanide is present and is used in crucial tests of the Tylenol,' former New York Times pharmaceutical reporter Gardiner Harris said in the series. He also pointed out that the company did most of the investigating themselves, even though they seemed to have 'every season to hide the extent of the contamination problems.'
The documentary reveals that potassium cyanide was used it a quality control tests of Tylenol and was found in the vicinity of where the pills were assembled.
In 1988, a court ruled that Johnson & Johnson wasn't liable for Diane Elsroth's death. The families of the Chicago victims also sued the company in 1983, claiming that the Johnson & Johnson knew that their bottles ould be tampered with. Johnson & Johnson settled the suit in 1991 and agreed to pay an undisclosed sum without admitting liability.
"Though there is no way we could have anticipated a criminal tampering with our product or prevented it, we wanted to do something for the families and finally get this tragic event behind us," Robert Kniffin, a spokesman for Johnson & Johnson, said at the time.
Bruce Pfaff, a lawyer for the plaintiffs, called the agreement 'a very favorable settlement for my clients.' Several of the families were seeking between $10 million and $15 million for wrongful death, pain and suffering, and funeral expenses, according to The New York Times.
A worker checks the newly implemented safety seals on Tylenol bottles shortly after the company's ... More re-release of Tylenol capsules in 1982. A few months earlier, a Chicago man poisoned Tylenol with cyanide, killing several people. | Location: Fort Washington, Pennsylvania, USA. (Photo by �� Leif Skoogfors/CORBIS/Corbis via Getty Images)
Johnson & Johnson was ultimately able to successfully re-launch Tylenol after the scare. The company overhauled its manufacturing process and introduced three separate safety seals to Tylenol packaging. First was an outer box with glued flaps. Second, a tight plastic neck seal covering the cap and neck of the bottle. And finally, a strong inner foil seal placed over the mouth of the bottle.
Four years after the original murders, on February 8, 1986, Diane Elsroth of Yonkers, New York, died after taking Extra-Strength Tylenol capsules that were found to contain cyanide, even though the bottle had a triple safety seal. Johnson & Johnson claimed at the time that someone had penetrated all the seals, resecured them, and returned the bottles to the shelf.
The Netflix documentary reported that two additional triple-sealed bottles of Tylenol were also found to contain the poison. Ultimately, the Westchester District Attorney was able to determine where the pills had been tampered with.
In the aftermath of the Tylenol poisonings, other pharmaceutical and food companies began implementing tamper-proof seals and safety indicators during the manufacturing process. These changes significantly reduced the number of copycat incidents.
'Before 1982, nobody thought twice about opening a bottle of painkillers,' Guendelman and Pines told Tudum. 'Today, every tamper-proof seal is a reminder of that dark moment — when cyanide-laced capsules transformed an everyday medicine into a murder weapon, permanently reshaping consumer industries."
Watch the official trailer for Cold Case: The Tylenol Murders below.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory
We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on Valueinvesting subreddit by bluespacecolombo. In this article, we will summarize the bulls' thesis on RARE. Ultragenyx Pharmaceutical Inc.'s share was trading at $27.61 as of July 28th. A scientist in a laboratory coat looking into a microscope at human bone regeneration samples. Ultragenyx Pharmaceutical (RARE) has seen its share price halve in just two weeks, largely due to a halted trial and an FDA rejection, but the market appears to have overreacted. The company's Phase 3 trial for setrusumab, a potential blockbuster therapy for a rare bone disease, failed to meet an early 'stop-for-efficacy' milestone, yet the study remains on track, with safety intact and final results expected in late 2025 under less stringent endpoints. Meanwhile, the FDA issued a complete response letter for another gene therapy candidate, citing manufacturing issues rather than safety or efficacy concerns. The program remains viable, with a resubmission expected once production adjustments are made. Despite these setbacks, Ultragenyx continues to generate meaningful revenue, posting $139 million in Q1 and guiding for over $640 million in 2025, and maintains a robust cash position of around $560 million, with management projecting lower cash burn. Beyond setrusumab, the company's pipeline is well diversified, featuring DTX401, a gene therapy for glycogen storage disease that met Phase 3 goals and is slated for FDA submission this year, as well as an advanced Angelman syndrome program in Phase 3. None of the recent regulatory or clinical updates involved failures of safety or efficacy, leaving the scientific foundation of the pipeline intact. Analysts' average price targets remain near $100, implying a potential threefold upside from the current ~$26 level. With solid fundamentals, multiple near-term catalysts, and a temporarily depressed valuation, Ultragenyx represents a compelling contrarian opportunity as panic-driven selling unwinds. Previously we covered a bullish thesis on Capricor Therapeutics, Inc. (CAPR) by androidmj in March 2025, which highlighted the upcoming FDA decision on Deramiocel, strong financial backing, and significant upside on approval. The company's stock has depreciated about 46.32% since then as the thesis has yet to play out. The thesis still stands given CAPR's cash runway and de-risked catalyst. bluespacecolombo shares a similar view on the biotech space but emphasizes Ultragenyx's diversified pipeline, overreaction-driven selloff, and near-term catalysts. Ultragenyx Pharmaceutical Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 55 hedge fund portfolios held RARE at the end of the first quarter which was 57 in the previous quarter. While we acknowledge the potential of RARE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
21 minutes ago
- Yahoo
Tesla Offers Musk $30 Billion to Stay--With Strings Attached
Tesla (NASDAQ:TSLA) just handed CEO Elon Musk a massive new stock awardworth around $30 billiondesigned to keep him anchored at the helm while the company weathers legal battles and business headwinds. The package includes 96 million shares at a $23.34 exercise price, and it only kicks in if Musk stays in a senior leadership role for another two years. It's a stopgap move while the board appeals a court decision that voided his original 2018 compensation plan. That plan, once pegged at $56 billion, has become a flashpoint for investors and governance advocates alike. The interim award signals Tesla's intent to keep Musk focused during a volatile phase for the business. Tesla's board calls this a good faith gestureand timing matters. After a tough first half marked by declining sales, falling revenue, and a 25% YTD drop in share price, the company is leaning heavily on Musk's leadership to navigate what it describes as a critical inflection point. According to Wedbush analyst Dan Ives, the new agreement helps remove a lingering cloud over the stock and likely cements Musk's role for the foreseeable future. The board is also developing a longer-term pay structure, to be voted on at the November 6 shareholder meeting. But leadership retention isn't the only thing on the line. Musk's attention has been split across multiple venturesSpaceX, xAI, X Corp, Neuralink, The Boring Companyand his recent political entanglements haven't helped. The board acknowledges these distractions but says Musk remains central to Tesla's ability to attract and retain talent. Meanwhile, Tesla is trying to build momentum around its new robotaxi program, launched in Austin, which could be a long-term growth lever. Whether this compensation reset keeps Musk focused on Teslaor just buys timeis what investors will be watching next. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
How to get free Burger King Whoppers for 6 days straight
Burger King and Walmart+ lovers to the front. The companies are offering a deal that'll give customers a free Whopper with a $1 purchase for six days straight. The deal is only available for shoppers who are members of both Walmart+ and Burger King Royal Perks programs, a Burger King representative told USA TODAY via email. The deal will run from Tuesday, Aug. 5, to Monday, Aug. 11. The special was announced to celebrate the one-year anniversary of Walmart and Burger King's first-ever joint promotion, launched last summer. Last year's deal gave Walmart+ members 25% off any Burger King digital order every day, as well as a free Whopper every three months starting in September 2024. Here's what to know to get the deal: Read more: Walmart+ members get 25% off Burger King, free Whoppers in new partnership How can I get my free Whopper this week? Guests can take advantage of the deal by linking their Burger King Royal Perks and Walmart+ accounts. To link your accounts: Make sure the Burger King app is downloaded on your device. Download the Walmart app and sign in. Or, log in at Go to "Account." Select "Walmart+ membership." Find the Burger King Savings benefit and select "Get started." The Burger King app should open automatically. Select the "Link accounts" button. Once customers have linked their Walmart+ and Burger King accounts, they can redeem the offer by: ordering in-store using their 6-digit code, opening the Burger King app, going to the 'Offers' tab and activating the offer, and logging in at to place an order. Did someone say diner? Elon Musk fans flock to new Tesla Diner Are there any restrictions? The deal is not available during breakfast hours except at select locations, and customers can only get one free Whopper per account each day, Burger King said. The offer cannot be used with delivery orders. More on Walmart+ and Burger King Royal Perks Walmart+ is Walmart's delivery program that starts at $12.95 a month or $98 annually. The program has student and government assistance eligibility, per the company's website. Royal Parks is Burger King's free rewards program that allows customers to earn points, or crowns, for every $1 spent on eligible transactions. Customers can then cash in the crowns for free menu items. Saleen Martin is a reporter on USA TODAY's NOW team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@ This article originally appeared on USA TODAY: Got Walmart+ and Burger King Royal Perks? Get a free Whopper.